Can pharmacogenomics testing improve my medication effectiveness?

Yes. By identifying how your body metabolises specific drugs, pharmacogenomics testing helps select medications that are more effective and better suited to your genetic profile, reducing the need for trial-and-error treatment.

Is pharmacogenomic testing FDA-approved?

Yes. Many pharmacogenomic tests and gene-drug guidelines have FDA recognition or approval. The FDA also provides pharmacogenomic labeling for specific medications that require or recommend genetic testing.

Are there any risks with pharmacogenetic testing?

Pharmacogenetic testing is generally safe, as it only requires a saliva or blood sample. The main considerations involve the privacy of genetic information and understanding test limitations, but there are no physical health risks.

Can pharmacogenomics testing improve my medication effectiveness?

Absolutely. Pharmacogenomics testing tailors medication choices to your genetic makeup, helping your doctor select the most effective drug and optimal dosage from the start.

Pharmacogenomics Testing: How Genes Affect Medication

Pharmacogenomics is a rapidly growing field, advancing medical science towards a new concept of personalised medicine. Pharmacogenomics includes genetics and pharmacology, transforming the age-old philosophy of “one-size-fits-all” medicine into a precision-based model. The term “pharmacogenomics” has been used more recently to convey the idea that variable drug response may reflect sets of variants within an individual or across a population.

One of the most important developments in personalised healthcare is pharmacogenomics testing. This includes examining the genes and their response to specific medications. Instead of relying on trial-and-error, doctors can now use genetic insights to choose drugs that are safer, more effective, and tailored to the individual.

This blog takes you through the science, applications, benefits, and future of pharmacogenomics and explores how personalised medicine in India is becoming increasingly accessible.

What Is Pharmacogenomics Testing?

Pharmacogenomics testing studies and analyses specific genes that influence how your body processes medications. Everyone inherits genetic variations that affect drug-metabolising enzymes, transporters, and receptors. These differences determine whether a medicine works well, causes side effects, or requires dose adjustments.¹

Pharmacogenetic tests help predict your response to certain medications, enabling clinicians to prescribe drugs with greater confidence. The goal is simple but powerful: the right drug, at the right dose, for the right patient.

Pharmacogenomics testing can revolutionise treatment decisions in areas like:

Cardiovascular diseases
In the field of Psychiatry- Depression
Oncology
Pain management
Infectious diseases

By understanding and identifying your unique genetic blueprint, clinicians can eliminate ineffective drugs, minimise adverse reactions, and improve overall treatment outcomes.

The Science Behind How Genes Affect Drug Response

Key Enzymes and Genetic Variants in Drug Metabolism

Genetic variations can influence the activity of Cytochrome P450 (CYP) drug-metabolising enzymes, which are responsible for processing approximately 70-80% of clinical drugs.² These enzymes are responsible for metabolising many drugs, and their activity can vary among individuals.

Certain genetic variations can result in altered enzyme activity, leading to differences in drug metabolism rates. For example, variations in the CYP2D6 gene can affect the metabolism of drugs such as codeine (a painkiller) and tamoxifen (used in the treatment of breast cancer), thereby altering their effectiveness or causing adverse effects.³

The following are the typical metabolic categories:

Poor metabolisers: Process drugs slowly, leading to high drug levels and risk of toxicity
Intermediate metabolisers: Slower than normal processing
Normal (extensive) metabolisers: Typical drug processing
Ultra-rapid metabolisers: Clear drugs too quickly, making them less effective

Some genes play an important role in how the body processes medications, which affects everything from how well a drug works to potential side effects. These pharmacogenes impact drug metabolism, transport, and response, and are often the focus of targeted pharmacogenomics testing.

Below are several of the most well-studied genes in this space:

CYP2D6: Involved in metabolising over 20% of commonly prescribed drugs, including antidepressants, opioids, and beta-blockers. Variants can lead to poor, intermediate, or ultra-rapid metabolism.⁴
CYP2C19: Plays a role in processing drugs like clopidogrel, proton pump inhibitors, and certain antidepressants. Genetic differences can affect whether a patient responds well or not at all.
VKORC1: Affects sensitivity to warfarin, a widely used blood thinner. Variants in this gene influence how much medication a patient needs to achieve safe, effective blood thinning. ⁵
TPMT: Impacts the metabolism of thiopurine drugs used in cancer and autoimmune conditions. Low TPMT activity increases the risk of toxicity if standard doses are given.⁶
SLCO1B1: Influences how statins are transported in the body. Certain variants raise the risk of muscle-related side effects, especially with higher statin doses.

From the above information, one can clearly understand the role of pharmacogenomics in effective drug treatment.

How Genes Affect Drug Response: The Complete Guide

Understanding How Genes Affect Drug Response and Efficacy

Every person’s genome carries subtle differences, called polymorphisms, that influence drug response. These differences affect:

Absorption: How well your body absorbs a drug
Distribution: How the drug travels through your bloodstream
Metabolism: How quickly it is broken down
Elimination: How efficiently it is removed
Receptor interaction: How effectively the drug binds to its target

It’s important to know how the body breaks down (metabolises) and removes medicines. Not every person’s body breaks down medicines at the same rate. It could be too fast or too slow for some people.

If some medicines break down too quickly, the level of the drug in a person’s body may be too low for it to work well. If some break down too slowly, the level of the drug in the body could be too high and cause side effects.

How the body turns on (activates) medicines is an interesting pathway. The body needs to activate, or turn on, some medicines for them to work. If the body is exposed to too much active medicine, it can cause side effects. Or a medicine might not work if the body doesn’t turn on enough of it.

Some genes can make a person more likely to have a rare but serious reaction to a medicine. If someone has one of these genes, doctors can choose a safer alternative medicine.⁷

Common Medications Influenced by Genetic Variations

Pharmacogenomics insights are especially valuable for drugs such as:

Mental health medications, including antidepressants like escitalopram (Lexapro) and sertraline (Zoloft), as well as antipsychotics
Pain medications, especially opioids
Heart medications, including blood thinners like warfarin (Coumadin) and clopidogrel (Plavix), and cholesterol medications like statins
Cancer therapies, including chemotherapy drugs and targeted therapies
Anti-seizure medications
Drugs used for organ transplants and immune conditions

Identifying genetic variations before prescribing these medications helps prevent serious complications and ensures better outcomes.

Genetic Testing for Medications: What You Need to Know

Types of Genetic Testing for Medications Available

Pharmacogenomics tests typically analyse multiple genes involved in drug metabolism, transport, and receptor binding. They may include:

Single-gene tests: For medications with a well-known genetic influence
Multi-gene panel tests: Broader insights for multiple drugs, useful in psychiatry, cardiology, oncology
Whole exome/genome-based pharmacogenomics: Expanding but still emerging for clinical use

A pharmacogenetic test uses a sample of saliva or blood, making them simple and minimally invasive. The sample is sent to a lab, which runs tests on genes that determine how the body will respond to certain medicines. Changes or differences in those genes could mean some medicines will work well for a person or that they might cause side effects.

Who Should Consider Genetic Testing for Medications?

Pharmacogenomics testing is especially recommended for a patient:

Having side effects from medications that work well for other people
Have tried different medications without success
About to start a new medication that’s known for gene-drug interactions
Having a condition that needs long-term or high-risk drug treatment
People with a family history of adverse drug reactions
Those on multiple medications (polypharmacy)

These tests will help clinicians to design the safest and most effective medications and also avoid long trials and guesswork.

Personalised Medicine in India: The Future of Healthcare

Availability of Personalised Medicine in India

India has a highly diverse population with significant genetic variability across communities. This diversity can influence how individuals respond to medications. For example, a percentage of Indians carry a mutation in the CYP2C19 gene, reducing the effectiveness of clopidogrel, a common blood thinner used after stent placement.⁸

MedGenome offers patients testing for various genes like CYP2C19, guiding treatment with targeted therapies. Pharmacogenomics in India is particularly impactful in:

Cardiovascular diseases (e.g., clopidogrel resistance)
Psychiatry (tailoring antidepressants and mood stabilisers)
Oncology (chemotherapy toxicity prediction)
General practice (safer pain medicines)

Pharmacogenetics is an emerging field in India as healthcare systems are getting reshaped and moving towards more precision-based approaches.

Benefits of Pharmacogenomics Testing for Patients

Pharmacogenomics testing offers a range of patient-centered benefits:

Improved and more effective medication: Better drug selection based on your genetic profile
Reduced adverse reactions: Avoiding harmful drugs and unsafe dosages. Typical doses of mercaptopurine used to treat ALL can cause severe side effects if you have a certain variant of the TPMT gene.⁹
Faster clinical improvement: Eliminating trial-and-error in selecting medications
Economically viable: Fewer hospital visits and treatment failures
Precision in treatment: Patients feel more secure knowing their therapy is tailored to them

For chronic conditions such as hypertension, depression, heart disease, and cancer, pharmacogenetics can be transformative.

Reducing Adverse Drug Reactions Through Pharmacogenomics Testing

Adverse drug reactions (ADRs) are a major healthcare concern. This occurs because the body responds to standard doses of medicine. With pharmacogenomics testing, clinicians can:

This helps to adjust doses to a patient’s metabolism
Find a medication likely to cause harm
Detect drug–drug interactions influenced by genetics.
Improve safety for elderly patients who take multiple drugs.

This preventive approach can definitely reduce medical complications and improve patient well-being.

The Future of Pharmacogenomics Testing and Precision Healthcare

Pharmacogenomics is a rapidly expanding and vital component of precision medicine. By understanding how an individual’s genes influence their response to medications, healthcare providers can make safer, faster, and more effective treatment decisions.

Information obtained through pharmacogenomic testing can help guide therapy selection, optimise dosing, and reduce the risk of adverse drug reactions.

Future advancements in this field include:

Routine pharmacogenomic testing before initiating major therapies
Integration of genomic data into electronic health records
Personalised drug development and genomically guided clinical trials
AI-driven prediction of drug response

With increasing awareness, improved testing technologies, and wider accessibility, India is well positioned to make pharmacogenomics a standard component of modern healthcare.

Conclusion

Pharmacogenomics testing is reshaping the way we understand and use medications. By revealing how your genes affect drug response, this approach empowers clinicians to choose more effective treatments with fewer risks. The benefits of pharmacogenomic testing for a patient include reduced drug toxicity and hospital admissions, improved treatment efficacy, and general health.

FAQs

Can pharmacogenomics testing improve my medication effectiveness?
Yes. By identifying how your body metabolises specific drugs, pharmacogenomics testing helps select medications that are more effective and better suited to your genetic profile, reducing the need for trial-and-error treatment.
Is pharmacogenomic testing FDA-approved?
Yes. Many pharmacogenomic tests and gene-drug guidelines have FDA recognition or approval. The FDA also provides pharmacogenomic labeling for specific medications that require or recommend genetic testing.
Are there any risks with pharmacogenetic testing?
Pharmacogenetic testing is generally safe, as it only requires a saliva or blood sample. The main considerations involve the privacy of genetic information and understanding test limitations, but there are no physical health risks.
Can pharmacogenomics testing improve my medication effectiveness?
Absolutely. Pharmacogenomics testing tailors medication choices to your genetic makeup, helping your doctor select the most effective drug and optimal dosage from the start.